These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 22571874)

  • 1. Pheochromocytoma and paraganglioma: imaging characteristics.
    Baez JC; Jagannathan JP; Krajewski K; O'Regan K; Zukotynski K; Kulke M; Ramaiya NH
    Cancer Imaging; 2012 May; 12(1):153-62. PubMed ID: 22571874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic approach of pheochromocytomas and paragangliomas].
    Gómez RM; Hernaiz M; de Miguel V; Aparicio LS; Marín MJ; Lupi S; Barontini M;
    Hipertens Riesgo Vasc; 2019; 36(1):34-43. PubMed ID: 30078655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
    Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
    J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma.
    Timmers HJ; Taieb D; Pacak K
    Horm Metab Res; 2012 May; 44(5):367-72. PubMed ID: 22399235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
    Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
    Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary paraganglioma-pheochromocytoma syndrome.
    Sanchez Cifuentes A; Candel Arenas MF; Albarracín Marín-Blazquez A
    Med Clin (Barc); 2018 Nov; 151(10):e57-e58. PubMed ID: 29656766
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
    Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
    Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paragangliomas and Pheochromocytomas: Positron Emission Tomography/Computed Tomography Diagnosis and Therapy.
    Marcus C; Subramaniam RM
    PET Clin; 2023 Apr; 18(2):233-242. PubMed ID: 36585340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy.
    Parasiliti-Caprino M; Lucatello B; Lopez C; Burrello J; Maletta F; Mistrangelo M; Migliore E; Tassone F; La Grotta A; Pia A; Reimondo G; Giordano R; Giraudo G; Piovesan A; Ciccone G; Deandreis D; Limone P; Orlandi F; Borretta G; Volante M; Mulatero P; Papotti M; Aimaretti G; Terzolo M; Morino M; Pasini B; Veglio F; Ghigo E; Arvat E; Maccario M
    Hypertens Res; 2020 Jun; 43(6):500-510. PubMed ID: 31586159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up.
    Stenman A; Zedenius J; Juhlin CC
    Surgery; 2019 Nov; 166(5):901-906. PubMed ID: 31239074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of pheochromocytoma and paraganglioma.
    Brink I; Hoegerle S; Klisch J; Bley TA
    Fam Cancer; 2005; 4(1):61-8. PubMed ID: 15883712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of fluorine-18-labelled deoxyglucose positron emission tomography with computed tomography to localize a paraganglioma in pregnancy.
    Koroscil TM; McDonald S; Stutes S; Vila RJ
    South Med J; 2010 Dec; 103(12):1238-42. PubMed ID: 21037527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry.
    Juhlin CC
    Endocr Pathol; 2021 Jun; 32(2):228-244. PubMed ID: 33768452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
    Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Diagnosis to Therapy-PET Imaging for Pheochromocytomas and Paragangliomas.
    Patel HV; Srivastava A; Becker MD; Beninato T; Laird AM; Singer EA
    Curr Urol Rep; 2021 Jan; 22(1):2. PubMed ID: 33403502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
    Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of Pheochromocytomas and Paragangliomas.
    Timmers HJLM; Taïeb D; Pacak K; Lenders JWM
    Endocr Rev; 2024 May; 45(3):414-434. PubMed ID: 38206185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging molecular markers of metastatic pheochromocytomas and paragangliomas.
    Goncalves J; Lussey-Lepoutre C; Favier J; Gimenez-Roqueplo AP; Castro-Vega LJ
    Ann Endocrinol (Paris); 2019 Jun; 80(3):159-162. PubMed ID: 31053249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma.
    Patel D; Phay JE; Yen TWF; Dickson PV; Wang TS; Garcia R; Yang AD; Solórzano CC; Kim LT
    Ann Surg Oncol; 2020 May; 27(5):1329-1337. PubMed ID: 32112212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.